Is the recommendation not to use rifampin plus pyrazinamide for latent tuberculosis treatment always imperative?
Angelo
A
Cazzadori
Benedetta
B
Allegranzi
Anna
A
Scardigli
Flavio
F
Favari
Ercole
E
Concia
D000904:Antibiotics, Antitubercular / Q000008:administration & dosage*; D000995:Antitubercular Agents / Q000008:administration & dosage*; D024901:Drug Resistance, Multiple, Bacterial; D004359:Drug Therapy, Combination; D006801:Humans; D011718:Pyrazinamide / Q000008:administration & dosage*; D012293:Rifampin / Q000008:administration & dosage*; D014376:Tuberculosis / Q000188:drug therapy*
D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D011718:Pyrazinamide; D012293:Rifampin